Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Moderna Says Feds Should’ve Been Sued in Vaccine Patent Dispute

May 6, 2022, 10:04 PM

Moderna Inc. is urging a Delaware federal court to throw out patent claims brought by Arbutus Biopharma Corp. and Genevant Sciences GmbH related to Moderna’s sale of Covid-19 vaccine doses to the U.S. government.

Genevant Sciences and Arbutus Biopharma sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine. The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission.

To the extent the patent claims are related to the sale of vaccine doses to the U.S. government, Moderna said in a Friday filing that Airbutus and Genevant sued the wrong party. It argues ...